Diagnostics Oncology, Microbiology and immunology, Histology, Genetics and epigenetics, Omics

Elucidating Tumor Heterogeneity in Prostate Cancer by Combined IHC & Novel RNA ISH

Assessment of molecular heterogeneity in tumor is a challenging task. For the first time, Palanisamy et al. have demonstrated the existence of a rare subset of prostate cancer with heterogeneous molecular aberrations involving ETS family genes and SPINK1 expression utilizing both standard immunohistochemistry (IHC) and RNA in situ hybridization (Advanced Cell Diagnostics RNAscope® Technology).

01/27/2015

sponsored by ACD

Visit our Webinar Hub

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.